Our Pipeline

Our pipeline leverages on our modular core technology to target tumor using enhanced CAR-T cells.

Product Target Enhancements Preclinical IND Phase I Phase II Phase III Next Milestone
TAVST01 To be disclosed Improve persistence
IND Submission
TAVST02 To be disclosed To be disclosed
Complete preclinical
TAVST03 To be disclosed To be disclosed
Proof of concept